SIEMENS HEALTH.AG NA O.N.
Commented by Stefan Feulner on November 18th, 2021 | 13:40 CET
Siemens Healthineers, Troilus Gold, TeamViewer - All is set
The stock markets continue to run upwards. Germany's leading index, the DAX 40, once again marked a new all-time high of over 16,250 points. Even though minor corrections are normal, market experts expect the next target to be in the area of 17,400 points. The chart picture on the gold market has also changed positively. Should the USD 1,900 per ounce mark be cracked, the precious metal is about to storm the old highs.
Read
Commented by Nico Popp on September 29th, 2021 | 10:18 CEST
Rheinmetall, Almonty Industries, Siemens Healthineers: Here the signs point to growth
In 2019, the world's nations spent a whopping USD 1917 billion on armaments. That is more than they have spent since 1988, stresses the Stockholm-based International Peace Research Institute. Germany increased its spending more than any other country in the process. The incidents in Afghanistan have shown that it is of great importance to be able to act if one wants to play a role on the international stage. The pandemic shows that health can also take on a global dimension. Here, too, experts expect rising expenditures. Reason enough to take a closer look at well-known representatives of both sectors.
Read
Commented by André Will-Laudien on September 16th, 2021 | 11:58 CEST
Siemens Healthineers, PuriflOH, Fresenius, Novavax - Focusing on health!
The pandemic outbreak in 2020 ushered in a new era. People's health is once again moving to the center of attention. Politicians worldwide see themselves obligated to make public life safe, but whether this will be 100% successful remains questionable. Ultimately, it will depend on the commitment of private companies to what extent the existing health issues can be solved and by what means. On the capital markets, the healthcare sector has been sailing on the highest wave for months because the dangers for billions of people need to be reduced, and framework conditions for public life need to be created. Who benefits the most?
Read
Commented by Armin Schulz on August 16th, 2021 | 13:27 CEST
BioNTech, XPhyto Therapeutics, Siemens Healthineers - Corona has triggered a boom
While many companies have suffered greatly from the Corona pandemic, there are also a number of winners. First and foremost, vaccine manufacturers but also diagnostics companies experienced substantial growth rates in sales. Irrespective of Corona, it is increasingly crucial for the healthcare sector to push ahead with digitization, especially in diagnostics. Here, digitization offers the opportunity to significantly increase the quality and speed of diagnoses through artificial intelligence. Time, in particular, is an important factor here. Today, we take a closer look at three beneficiaries of the Corona Crisis.
Read
Commented by Stefan Feulner on August 3rd, 2021 | 12:22 CEST
Siemens Healthineers, Cardiol Therapeutics, BioNTech - Tomorrow's blockbusters
The fight against the coronavirus and the possible return to everyday life promises companies in the biotechnology sector billions in profits. At the forefront, vaccine producers such as BioNTech with its pharmaceutical partner Pfizer or Moderna are the primary beneficiaries of the pandemic. In addition, start-ups are emerging from the diagnostics and therapy sectors, whose formulations have blockbuster potential and could follow a similar path to the vaccine manufacturers in the coming years.
Read
Commented by Nico Popp on July 20th, 2021 | 13:42 CEST
Siemens Healthineers, Cardiol Therapeutics, CureVac: Where there is music to be heard by the end of the year
Health is the highest good. Anyone who has ever experienced people having the "plug pulled" on them overnight can undoubtedly relate to this truism. Fortunately, medicine in this country is able to provide a quick remedy. A wide range of options are available for both diagnosis and therapy. In addition to laboratory analyses, imaging procedures also ensure that disease patterns can be narrowed down and, thus, treatments can be carried out in a targeted manner. Although our drugs are already powerful, new, more innovative approaches are emerging all the time. This development is also benefiting investors.
Read
Commented by Armin Schulz on July 19th, 2021 | 11:11 CEST
BioNTech, Defence Therapeutics, Siemens Healthineers - Winning the fight against cancer
There are over 200 different types of cancer where degenerate cells begin to form tumors. The cost of the disease is estimated at USD 1,160,000,000,000 worldwide. It is no wonder that a lot of money goes into researching cancer drugs. Whoever makes the breakthrough here can make a lot of money. It would be desirable that one of the three companies presented today could find a solution, as that could save 9.6 million people a year. But it is not only drugs that promise profits but also prevention and diagnostics. Today we highlight three companies that have joined the fight against cancer.
Read
Commented by Nico Popp on July 1st, 2021 | 11:12 CEST
Siemens Healthineers, Royal Helium, Linde: Three stocks with momentum
Good health is the most valuable commodity. Especially those who have everything materially want nothing more than to remain healthy in the case of illness. People are also becoming more circumspect when it comes to preventive checkups. A few years ago, the cliché prevailed that men, in particular, gave doctors a wide berth. Today, prevention and regular checkups are considered a must. In this context, imaging techniques are becoming increasingly important: Whether an intervertebral disc or cardiovascular problem - modern medical technology equipment allows doctors to closely monitor and make the appropriate diagnoses.
Read
Commented by Nico Popp on June 25th, 2021 | 14:01 CEST
BYD, Siemens Healthineers, Silver Viper: Many trends in one share
Trends and hypes on the stock market are not always easy: Sometimes they are slow, then there are dynamic upward phases, and sometimes you need patience. Whether it is electromobility, renewable energy or the latest developments in medical technology, no one knows when prices will rise. What is certain, however, is that all of the industries mentioned have a future. So how do you invest? We outline three stocks around the mentioned industries.
Read
Commented by Nico Popp on March 17th, 2021 | 07:25 CET
Fresenius SE, Q+M Dental Group, Siemens Healthineers: Where growth meets dividends
The back-and-forth surrounding AstraZeneca's vaccine has unsettled many people. But the discussion about extremely rare side effects also shows: Vaccines and drugs are subject to strict regulations and the healthcare system is strictly regulated. While pharmaceutical companies must always expect setbacks, especially in accelerated approval procedures, the situation is different for suppliers of medical technology or consumables. We present three stocks that are benefiting from rising healthcare spending.
Read